Collegium Pharmaceutical, Inc. COLL Deferred Tax Assets and Other Non-Current Assets
Deferred Tax Assets and Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets?
- Collegium Pharmaceutical, Inc. (COLL) reported deferred tax assets and other non-current assets of $16.06M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets changed year-over-year?
- Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets increased by 218.9% year-over-year, from $5.04M to $16.06M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s deferred tax assets and other non-current assets has grown at a 177.4% compound annual growth rate (CAGR), from $123K to $20.19M.